GT Biopharma, Inc. (GTBP)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Dec. 2, 2025 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. The company is seeking to have the re… | Read Filing EDGAR |
| Jul. 1, 2025 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
| Jun. 27, 2025 | CORRESP | Concern from SEC | Moderate | GT Biopharma, Inc. has submitted a response to the SEC's comment letter regarding their Registration Statement on Form S-1, originally filed on June 11, 2025. The SEC raised conce… | Read Filing EDGAR |
| Jun. 20, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of GT Biopharma's registration statement on Form S-1 filed on June 11, 2025, and has issued a comment regarding the disclosure of Greenshoe … | Read Filing EDGAR |